To understand the possible disruption of the FAM72A-UNG2 interaction, the current investigation conducted an in silico prediction of FAM72A-UNG2 heterodimer–protein interaction and the identification of potential chemicals that interfere with the FAM72A-UNG2 heterodimer protein activity for the potential treatment of cancer. This evidence concerns the gene FAM72A and cancer.